Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

This study has been completed.
Sponsor:
Information provided by:
Bayside Health
ClinicalTrials.gov Identifier:
NCT00163631
First received: September 11, 2005
Last updated: October 3, 2006
Last verified: September 2005
  Purpose

Investigate vasoactive medicators in portal hypertension on stored sera


Condition
Portal Hypertension

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Resource links provided by NLM:


Further study details as provided by Bayside Health:

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • portal hypertension

Exclusion Criteria:

  • Nil
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00163631

Locations
Australia, Victoria
Alfred Hospital
Melbourne, Victoria, Australia, 3181
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: William W Kemp, MBBS FRACP The Alfred
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00163631     History of Changes
Other Study ID Numbers: 4104
Study First Received: September 11, 2005
Last Updated: October 3, 2006
Health Authority: Australia: Human Research Ethics Committee

Additional relevant MeSH terms:
Hypertension
Hypertension, Portal
Liver Cirrhosis
Cardiovascular Diseases
Digestive System Diseases
Liver Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on November 20, 2014